FIELD: medicine.
SUBSTANCE: therapeutic agent contains anastrozole, poly(lactic-co-glycolic acid), polyvinyl alcohol and D-mannitol. The therapeutic agent represents sub-micron particles and can be presented in the form of capsules, granules, powder, as well as a suspension for injections.
EFFECT: using the developed therapeutic agent enables achieving the therapeutic effect with lower therapeutic doses and making the antitumour therapy more comfortable for the patient.
2 cl, 1 tbl, 2 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PROLONGED ACTION THERAPEUTIC AGENT BASED ON ANASTROZOLE | 2017 |
|
RU2659689C1 |
| POLYMER CONTAINING MEDICINAL AGENT BASED ON ANTITUMOR AGENT ETOPOSIDE | 2015 |
|
RU2595859C1 |
| ANTICANCER DRUG BASED ON NICLOSAMIDE | 2016 |
|
RU2617049C1 |
| DRUG PREPARATION FOR PARKINSON DISEASE | 2014 |
|
RU2545734C1 |
| ANTI-TUMOUR PREPARATION | 2011 |
|
RU2451509C1 |
| METHOD FOR OBTAINING POLYMERIC ANTI-TUMOR PARTICLES IN FLOW MICROREACTOR AND LYOPHILISATE BASED ON THEM | 2018 |
|
RU2681933C1 |
| RIFAMPICIN-BASED MEDICATION WITH PROLONGED ACTION FOR TREATMENT OF RESISTENT FORMS OF TUBERCULOSIS | 2010 |
|
RU2418585C1 |
| DRUG OF ANTI-TUBERCULOSIS ACTION ON THE BASIS OF D-CYCLOSERINE IN THE FORM OF A LYOPHILISATE AND METHOD OF PRODUCING A MEDICINAL PREPARATION | 2015 |
|
RU2606839C1 |
| ANTIMICROBIAL MEDICINAL AGENT, METHOD OF PRODUCTION OF DIRECTIONAL MEDICINAL AGENT CONTAINIG NANOPARTICLES | 2007 |
|
RU2327459C1 |
| POLYMERIC COMPLEX FOR MOLECULAR TARGETING THERAPY AND METHOD FOR ITS OBTAINING | 2017 |
|
RU2675810C1 |
